Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
05/08/2008 | US20080108123 Fe2O3 complexed biopolymer matrix for use in separation, isolation and delivery of cells, bacteria, drug elements; drug screening |
05/08/2008 | US20080108119 Method, Chip, Device and System for Extraction of Biological Materials |
05/08/2008 | US20080108111 Generating adenosine triphosphate via contacting adenosine monophosphate with phosphotransferase and adenylate kinase in presence of polyphosphate |
05/08/2008 | US20080108109 Biosynthesis of TA antibiotic |
05/08/2008 | US20080108108 Novel p. pastoris pastoris promoters, and the use thereof to direct expression of proteins in yeast, preferably using a haploid mating strategy |
05/08/2008 | US20080108107 Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits |
05/08/2008 | US20080108105 Transcription factor for enhancing genic expression in microorganismal host |
05/08/2008 | US20080108089 Methods for predicting pregnancy outcome in a subject by hCG assay |
05/08/2008 | US20080108088 Using g protein coupled receptor to identify modulators of taste signal transduction; generating of taste topographic maps that elucidate relationship between taste cells of tongue and taste sensory neurons in brain |
05/08/2008 | US20080108075 Using presence of single nucleotide polymorphisms as evaluative tools in predicting alzheimers disease |
05/08/2008 | US20080108067 Cloning of the retinoic acid inducible gene-1 promoter and uses thereof |
05/08/2008 | US20080108061 Using concentration of cancer-associated gene products as diagnostic tool in detection of cell proliferative disorders |
05/08/2008 | US20080108060 Polynucleotides for the Detection of Staphylococcus Aureus |
05/08/2008 | US20080108056 Method of Detecting the Expression of Aspergillus Gene |
05/08/2008 | US20080108052 Use of Ribozymes in the Detection of Adventitious Agents |
05/08/2008 | US20080107773 Food additive with a PS4 variant polypeptide derivable from a parent polypeptide having non-maltogenic exoamylase activity; baked goods; glucan 1,4-alpha-maltotetrahydrolase activity |
05/08/2008 | US20080107714 Use of a vector comprising a nucleic acid encoding an anti-angiogenic factor for the treatment of corneal neovascularization |
05/08/2008 | US20080107705 Administering locally for disc disorders |
05/08/2008 | US20080107700 Pesticide for transgenic crops; molluscs; wood pests |
05/08/2008 | US20080107693 Hybrid or chimeric polynucleotides, proteins, and compositions comprising hepatitis B virus sequences |
05/08/2008 | US20080107692 Fusion proteins; immunogens; host cells; diagnostic kits |
05/08/2008 | US20080107691 Vibrio cholerae strains vcusm1 and vcusm4, method of producing same, and vaccine derivatives thereof |
05/08/2008 | US20080107683 Bacterial Packaging Strains Useful for Generation and Production of Recombinant Double-Stranded RNA Nucleocapsids and Uses Thereof |
05/08/2008 | US20080107676 Using neisserial surface protein nucleotide sequences as tool in detection, prevention and treatment of microorganismal infection; immunodiagnostics; immunotherapeutics; vaccine development |
05/08/2008 | US20080107675 Using neisserial surface protein nucleotide sequences as tool in detection, prevention and treatment of microorganismal infection; immunodiagnostics; immunotherapeutics; vaccine development |
05/08/2008 | US20080107674 Proteinase k resistant surface protein of neisseria meningitidis |
05/08/2008 | US20080107673 Clostridial polypeptide for use in prevention and treatment of microorganismal infcetion |
05/08/2008 | US20080107672 Mutant viral antigen for use in diagnosing hepatitis; immunoassay |
05/08/2008 | US20080107667 Fusion peptide for use in targeting cells for lympocytic destruction; immunotherapy |
05/08/2008 | US20080107662 Immunogenic Peptides, Nucleic Acids Encoding The Same And Use Thereof In Cancer Treatment And Diagnosis |
05/08/2008 | US20080107659 Pharmaceutical Compositions for the Prevention and Treatment of Atherosclerosis and Restenosis After PTCA |
05/08/2008 | US20080107658 Nerve growth specific chimerikc ligand comping immunoglobulin component for use in treatment and prevention of arthritic, skin, viral, inflammatory, respiratory and pain disorders |
05/08/2008 | US20080107656 Plasmodium specific immunoglobulin for use in prevention and treatment of parasitic infection; parasiticides |
05/08/2008 | US20080107654 Immunloglobulin specific for calcium transport membrane protein for use in prevention and treatment of hematological disorders |
05/08/2008 | US20080107653 Heat resistant, chimeric verotoxin subunits for use in developing vaccine for prevention and treatment of microorganismal infection |
05/08/2008 | US20080107645 Antibody raised against a parasitic protozoan isolate; diagnostic assays for the detection of parasites in animals |
05/08/2008 | US20080107643 Transmembrane polypeptide for use in identifying modulators for prevention and treatment of cell proliferative, fibrotic and sclerotic disorders |
05/08/2008 | US20080107633 Cultures of human CNS neural stem cells |
05/08/2008 | US20080107631 Liquid mixture comprising cryoprotectants and lyoprotectants for use in long term storage of viral particles |
05/08/2008 | US20080107627 Use of sarp-1 for the treatment and/or prevention of scleroderma |
05/08/2008 | US20080107620 Human Cytomegalovirus Immunotherapy |
05/08/2008 | US20080107605 From a clone comprising complete nucleotide sequence for the expression of the TSH |
05/08/2008 | US20080107604 Method for the Prediction of the Risk Potential for Cancerous Diseases and Inflammatory Intestinal Diseases and Corresponding Tests |
05/08/2008 | US20080107602 Neospora caninum isolate |
05/08/2008 | US20080107600 Gene Marker And Composition For Diagnosis And Treatment Of Neurological Disorders And Diseases And Use Of The Same |
05/08/2008 | DE102006051516A1 (Basen-)modifizierte RNA zur Expressionssteigerung eines Proteins (Base-) modified RNA to increase in expression of a protein |
05/08/2008 | CA2674238A1 Targeting nbs1-atm interaction to sensitize cancer cells to radiotherapy and chemotherapy |
05/08/2008 | CA2671310A1 Bead based receptor biology |
05/08/2008 | CA2668554A1 Method for identification of compound having anti-anxiety effect |
05/08/2008 | CA2668285A1 Pathotropic targeted gene delivery system for cancer and other disorders |
05/08/2008 | CA2668041A1 Crop grain filling gene gif1 and the applications thereof |
05/08/2008 | CA2668027A1 Fgfr4 promotes cancer cell resistance in response to chemotherapeutic drugs |
05/08/2008 | CA2668017A1 Improved conjugates |
05/08/2008 | CA2667971A1 Adipocyte-specific constructs and methods for inhibiting platelet-type 12 lipoxygenase expression |
05/08/2008 | CA2667970A1 Monoclonal antibodies and fragment thereof directed against the human anti-mullerian hormone type ii receptor (amhr-ii) |
05/08/2008 | CA2667690A1 Insect inhibition by plant serpin |
05/08/2008 | CA2667617A1 Microrna expression signature for predicting survival and metastases in hepatocellular carcinoma |
05/08/2008 | CA2667255A1 Poultry vaccine, for necrotic enteritis, comprising a mutated clostridium perfringens alpha toxin antigen, and methods of producing the vaccine |
05/08/2008 | CA2667148A1 Use of the ocp3 mutation to regulate drought resistance in plants |
05/08/2008 | CA2667141A1 Novel polypeptides and uses thereof |
05/08/2008 | CA2666754A1 Soybean event dp-305423-1 and compositions and methods for the identification and/or detection thereof |
05/08/2008 | CA2664343A1 High affinity human antibodies to human il-4 receptor |
05/08/2008 | CA2664308A1 Dna composition for eliciting an immune response against tumor-associated macrophages |
05/08/2008 | CA2648921A1 Immunosuppressant binding antibodies and methods of obtaining and using same |
05/08/2008 | CA2636788A1 Pharmaceuticals that promote functional regeneration of damaged tissues |
05/08/2008 | CA2634783A1 Anti-hyperproliferative therapies targeting hdgf |
05/07/2008 | EP1918386A1 Gene expression profiling in biopsied tumor tissues |
05/07/2008 | EP1918380A2 Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof |
05/07/2008 | EP1918379A1 Expression vectors for multiple gene integration and Overexpression of homologous and heterologous proteins in yeasts of the species Arxula |
05/07/2008 | EP1918378A1 PSOD expression units |
05/07/2008 | EP1918377A1 Mammalian cytokine receptor subunit proteins, related reagents and methods |
05/07/2008 | EP1918376A1 FGFR4 promotes cancer cell resistance in response to chemotherapeutic drugs |
05/07/2008 | EP1918375A1 D-amino acid oxidase, and method for production of l-amino acid, 2-oxo acid or cyclic imine |
05/07/2008 | EP1918374A1 Novel diglycosidase and gene encoding the same |
05/07/2008 | EP1918373A1 Anti-obesity agent and anti-obesity food |
05/07/2008 | EP1918372A1 Nucleic acid capable of binding to immunoglobulin g and use thereof |
05/07/2008 | EP1918371A1 Novel phospholipid processing agent |
05/07/2008 | EP1918370A1 Mutant pcna |
05/07/2008 | EP1918369A1 A method of secretion expression of lysostaphin in escherichia coli at high level |
05/07/2008 | EP1918367A2 Desaturase Enzymes |
05/07/2008 | EP1918304A1 Monoclonal antibodies against the human anti-müllerian hormone type II receptor (AMHR-II) |
05/07/2008 | EP1918303A2 method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-egp-2 scfv fragment |
05/07/2008 | EP1918302A2 Methods for the identification and the isolation of epitope specific antibodies |
05/07/2008 | EP1918287A2 LPA receptor agonists and antagonists and methods of use |
05/07/2008 | EP1918018A2 Apparatus for concentrating and purifying nucleic acid |
05/07/2008 | EP1917975A1 Novel proteins in Enteroaggregative Escherichia Coli (EAEC) useful for diagnosis and therapy of EAEC infections |
05/07/2008 | EP1917360A2 Compositions providing tolerance to multiple herbicides and methods of use thereof |
05/07/2008 | EP1917359A2 Ce43-67b, insecticidal transgenic cotton expressing cry1ab |
05/07/2008 | EP1917358A2 Ce44-69d insecticidal transgenic cotton expressing cry1ab |
05/07/2008 | EP1917357A2 Multivalent rna nanoparticles for delivery of active agents to a cell |
05/07/2008 | EP1917356A2 Production of reprogrammed cells with restored potential |
05/07/2008 | EP1917350A2 A biological bypass bridge with sodium channels, calcium channels and/or potassium channels to compensate for conduction block in the heart |
05/07/2008 | EP1917347A2 Compositions and methods for analyzing protein interactions |
05/07/2008 | EP1917274A2 Vivit polypeptides, therapeutic agent comprising the same, and method of screening for anti-cancer agent |
05/07/2008 | EP1916903A2 Use |
05/07/2008 | EP1858318A4 A non-naturally occurring animal that expresses an untranslated non-coding rna |
05/07/2008 | EP1784506A4 Lentiviral vectors and uses thereof |
05/07/2008 | EP1766019A4 Modified plant transcription factors |
05/07/2008 | EP1759000A4 Polynucleotides for the detection of escherichia coli |
05/07/2008 | EP1740039A4 Novel herbicide resistance genes |